{"filing":{"accession_number":"0001193125-26-279427","cik":"0001676725","ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"d39019d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526279427/d39019d8k.htm"},"events":[{"id":13145,"run_id":11666,"accession_number":"0001193125-26-279427","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"IDEAYA held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on three proposals: election of three Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing reports the tabulated vote counts for each proposal.","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10210,"accession_number":"0001193125-26-279427","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the tabulated results of IDEAYA's 2026 Annual Meeting of Stockholders held on June 16, 2026, covering three proposals: election of three Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing presents vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:07:11.449183+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":13146,"run_id":11666,"accession_number":"0001193125-26-279427","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Effective June 16, 2026, the Board elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as Lead Independent Director, representing material governance restructuring of board leadership and oversight roles.","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10211,"accession_number":"0001193125-26-279427","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The Board elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as Lead Independent Director, effective June 16, 2026. These are governance leadership changes that affect board structure and oversight roles. While not a named executive appointment or departure, the elevation of the CEO to Chairman and designation of a Lead Independent Director represent material governance restructuring that would inform investor assessment of board composition and independence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:07:11.449183+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10210,"accession_number":"0001193125-26-279427","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the tabulated results of IDEAYA's 2026 Annual Meeting of Stockholders held on June 16, 2026, covering three proposals: election of three Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. The filing presents vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:07:11.449183+00:00","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-23"},{"id":10211,"accession_number":"0001193125-26-279427","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The Board elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as Lead Independent Director, effective June 16, 2026. These are governance leadership changes that affect board structure and oversight roles. While not a named executive appointment or departure, the elevation of the CEO to Chairman and designation of a Lead Independent Director represent material governance restructuring that would inform investor assessment of board composition and independence.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:07:11.449183+00:00","company_name":"IDEAYA Biosciences, Inc.","ticker":"IDYA","filing_date":"2026-06-23"}]}